CN203075198U - Disposable pre-filled injection type potassium magnesium aspartate medicine dissolving device - Google Patents
Disposable pre-filled injection type potassium magnesium aspartate medicine dissolving device Download PDFInfo
- Publication number
- CN203075198U CN203075198U CN 201220725052 CN201220725052U CN203075198U CN 203075198 U CN203075198 U CN 203075198U CN 201220725052 CN201220725052 CN 201220725052 CN 201220725052 U CN201220725052 U CN 201220725052U CN 203075198 U CN203075198 U CN 203075198U
- Authority
- CN
- China
- Prior art keywords
- dissolving device
- injection type
- medicine dissolving
- syringe
- ampoule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
The utility model relates to a disposable pre-filled injection type potassium magnesium aspartate medicine dissolving device which comprises a disposable injector, an agent bottle and a container. Potassium magnesium aspartate freeze-dried powder injection is injected into the agent bottle in a pre-filled mode. The container is provided with an area which is used for containing the injector, and an area which is used for containing the agent bottle. The disposable pre-filled injection type potassium magnesium aspartate medicine dissolving device is a compound device combining the potassium magnesium aspartate freeze-dried powder injection for injection and the disposable injector, a medicine preparation and the injector are packaged in the container in a unified mode, production and quality testing of products are convenient, and the products can also be conveniently transported and carried. When the disposable pre-filled injection type potassium magnesium aspartate medicine dissolving device is applied to medical treatment departments, use is quite convenient, working difficulty of medical workers is reduced, working efficiency is improved, and errors or mistakes in work can be effectively avoided. From the perspective of a patient, risks of cross infection when medicine is injected are reduced.
Description
Technical field
This utility model belongs to field of medicaments, relates to a kind of medicine dissolving device, especially relates to a kind of disposable use pre-filling injection type medicine dissolving device.
Background technology
In the injection room or the therapeutic room of hospital, medical personnel often will carry out the medicine injection to the patient at present.Usually, the nurse need open injector package, and for example the disposable syringe packing is opened ampoule simultaneously, and for example ampoule bottle or cillin bottle carry out the preparation of the injection of medicine then in ampoule by syringe.Because syringe and ampoule are isolating, the phenomenon of shortage usually can appear, especially when the injector package breakage causes calcellation or ampoule quality problems to occur in actual medical and nursing work.In the urgent rescue process of going out, the unmatched situation of syringe and ampoule also can appear, and the factor amount is carried deficiency and is influenced medical and nursing work.In addition, syringe and ampoule are produced respectively and are packed, owing to lack unified form, will cause production efficiency not high, can not satisfy the demand of medical and nursing work.For the potassium magnesium aspartate for injection lyophilized injectable powder, more press for and take unified production and manner of packing to offer the medical market.
Summary of the invention
Based on above-described variety of problems, the purpose of this utility model is to provide a kind of disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device.
Disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device described in the utility model comprises: disposable syringe; The pre-ampoule that fills potassium magnesium aspartate freeze dried powder injection; And container, have the zone that holds described syringe, and have the zone that holds described ampoule.
According to the further feature of disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device described in the utility model, the zone that holds described syringe in the described container can hold at least one described syringe.
According to the further feature of disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device described in the utility model, described syringe has independently and packs.
According to the further feature of disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device described in the utility model, the zone that holds described ampoule in the described container can hold at least one described ampoule.
According to the further feature of disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device described in the utility model, described ampoule is a vial.Preferably, described vial is to be selected from cillin bottle or ampoule bottle.
According to the further feature of disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device described in the utility model, the quantity of described syringe can be identical with the quantity of described ampoule, also can be different.
According to the further feature of disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device described in the utility model, the needle tubing of described syringe is enclosed in the syringe needle cover.
According to the further feature of disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device described in the utility model, the needle tubing of described syringe and syringe needle are isolating; Has the zone that holds described needle tubing and described syringe needle respectively in the described container.
Compared with prior art, disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device described in the utility model has the following advantages:
(1) provides the set composite of potassium magnesium aspartate for injection lyophilized injectable powder and disposable syringe, medicine preparation and syringe unitizing in a container, have been convenient to production and quality inspection, also be convenient to Product transport and carry.
(2) medicine dissolving device described in the utility model is used for medical department, very easy to use, reduced medical personnel's working strength, provide work efficiency, miswork of effectively avoiding or error.For the patient, the cross infection risk when also having reduced drug for injection.
Description of drawings
Fig. 1 is the sketch map of disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device described in the utility model.
Fig. 2 is the needle tubing of syringe described in the utility model and the sketch map that syringe needle is in released state.
The specific embodiment
As shown in Figure 1, according to disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device described in the utility model, comprising: disposable syringe 1; The pre-ampoule 2 that fills potassium magnesium aspartate freeze dried powder injection; And container 3.This container has the zone 4 that holds described syringe, and has the zone 5 that holds described ampoule.
As shown in Figure 1, hold a syringe 1 in the zone 4 of container 3, but also can hold more syringe 1.This syringe 1 can be various dissimilar syringes such as 5ml syringe, or 10ml syringe.
The syringes 1 that held in the zone 4 in the container 3 can have and independently pack 8.
As shown in Figure 1, hold an ampoule 2 in the zone 5 of container 3, but also can hold more ampoule 2.This ampoule 2 is selected vial usually for use, for example is selected from cillin bottle or ampoule bottle.
According to actual user demand, the quantity of syringe 1 can be identical with the quantity of ampoule 2, also can be different.
According to actual user demand, the needle tubing 6 of syringe 1 can overlap with syringe needle 7 and be enclosed in, as shown in Figure 1.The needle tubing 6 and the syringe needle 7 of syringe 1 also can be isolating, as shown in Figure 2; Correspondingly, in the container 3 zone that holds needle tubing 6 and syringe needle 7 will be set respectively.
Claims (10)
1. disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device, it is characterized in that: described medicine dissolving device comprises:
Disposable syringe;
The pre-ampoule that fills potassium magnesium aspartate freeze dried powder injection; And
Container has the zone that holds described syringe, and has the zone that holds described ampoule.
2. disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device according to claim 1 is characterized in that: the zone that holds described syringe in the described container can hold at least one described syringe.
3. disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device according to claim 1 and 2 is characterized in that: described syringe has independently and packs.
4. disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device according to claim 1 is characterized in that: the zone that holds described ampoule in the described container can hold at least one described ampoule.
5. according to claim 1 or 4 described disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving devices, it is characterized in that: described ampoule is a vial.
6. disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device according to claim 5, it is characterized in that: described vial is to be selected from cillin bottle or ampoule bottle.
7. disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device according to claim 1, it is characterized in that: the quantity of described syringe is identical with the quantity of described ampoule.
8. disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device according to claim 1, it is characterized in that: the quantity of described syringe is different with the quantity of described ampoule.
9. disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device according to claim 1 is characterized in that: the needle tubing of described syringe is enclosed in the syringe needle cover.
10. disposable use pre-filling injection type motassium magnessium aspartate medicine dissolving device according to claim 1, it is characterized in that: the needle tubing of described syringe and syringe needle are isolating; Has the zone that holds described needle tubing and described syringe needle respectively in the described container.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201220725052 CN203075198U (en) | 2012-12-26 | 2012-12-26 | Disposable pre-filled injection type potassium magnesium aspartate medicine dissolving device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201220725052 CN203075198U (en) | 2012-12-26 | 2012-12-26 | Disposable pre-filled injection type potassium magnesium aspartate medicine dissolving device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN203075198U true CN203075198U (en) | 2013-07-24 |
Family
ID=48821084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201220725052 Expired - Fee Related CN203075198U (en) | 2012-12-26 | 2012-12-26 | Disposable pre-filled injection type potassium magnesium aspartate medicine dissolving device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN203075198U (en) |
-
2012
- 2012-12-26 CN CN 201220725052 patent/CN203075198U/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007100779A3 (en) | Bottle with adapter for receiving needleless syringe | |
| Centers for Disease Control and Prevention (CDC | Invasive Staphylococcus aureus infections associated with pain injections and reuse of single-dose vials--Arizona and Delaware, 2012 | |
| CN203075198U (en) | Disposable pre-filled injection type potassium magnesium aspartate medicine dissolving device | |
| CN202036526U (en) | Triple layer co-extrusion film powder-liquid double room infusion bag | |
| CN203235096U (en) | Combined type injector | |
| CN203154435U (en) | Pre-irrigation bag-type infusion set | |
| CN202459095U (en) | Multiple bagged/bottled infusion drug preparing box | |
| CN201871024U (en) | Disposable porous medicine dissolving device | |
| CN205391301U (en) | Medical care car with mixed subassembly of medicine | |
| CN201312939Y (en) | Self-provided liquid type card bottle | |
| CN201871021U (en) | Disposable prefilled syringe type medicine solution apparatus | |
| CN208552350U (en) | Disposable sterilized treatment bag | |
| CN202704197U (en) | Safe and practical drug box packaging structure | |
| CN201240609Y (en) | Integral package of powder injection cartridge bottle prefilling injection apparatus | |
| CN202314360U (en) | Cefbuperazone sodium dual-chamber transfusion package for injection | |
| CN2880062Y (en) | Large transfusion bag of mixing powder and liquid instantly | |
| CN2880101Y (en) | Medical medicine-dispenser | |
| CN201061615Y (en) | Ampule filled with injection | |
| CN2887298Y (en) | Dual-chambered transfusion bag package of ceftazidime | |
| CN201784924U (en) | Combination package of powder injection | |
| Reynolds | The market need for reconstitution systems | |
| CN201743864U (en) | Emergency service vehicle | |
| CN2887299Y (en) | Dual-chambered transfusion bag package of cefepime sodium | |
| CN2863132Y (en) | Drain needle | |
| CN205598229U (en) | Rack is concentrated to syringe that dispenses |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130724 Termination date: 20181226 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |